KIAA0141 (DAP3 binding cell death enhancer 1) is a protein involved in cellular processes that can be activated by a range of chemical compounds through various biochemical mechanisms. Certain compounds can increase intracellular cyclic AMP (cAMP) levels, thereby activating protein kinase A (PKA). This activation can lead to a cascade of phosphorylation events, ultimately affecting the signaling pathways that KIAA0141 is involved in. Other chemicals can directly act on adenylate cyclase to boost cAMP levels, setting off similar pathways that culminate in heightened KIAA0141 activity. Additionally, there are compounds that can modulate the beta-adrenergic receptors, which may trigger signaling cascades that influence the regulatory mechanisms of KIAA0141, leading to an indirect increase in its activity.
There are activators that work by affecting the intracellular calcium concentration, either through ionophores or by stabilizing protein interactions that influence calcium signaling, which can have downstream effects on regulatory pathways pertinent to KIAA0141 function. The role of nitric oxide in cellular signaling is also pertinent, as some compounds can release this molecule, subsequently affecting signaling pathways that could have implications for KIAA0141 activity. Furthermore, alterations in the phosphorylation state of proteins through the inhibition of protein phosphatases or the activation of stress-activated protein kinases can also modulate pathways that indirectly lead to increased KIAA0141 activity.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
A synthetic catecholamine that activates beta-adrenergic receptors, possibly triggering a signaling cascade that increases KIAA0141 activity. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates protein kinase C (PKC), which could then modulate signaling pathways influencing KIAA0141 function. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Calcium ionophore that increases intracellular calcium concentration, potentially affecting KIAA0141 activity through calcium-dependent pathways. | ||||||
Fusicoccin | 20108-30-9 | sc-200754 sc-200754A sc-200754B | 1 mg 5 mg 10 mg | $416.00 $2081.00 $4162.00 | 7 | |
Stabilizes the interaction between 14-3-3 proteins and plasma membrane H+-ATPases, possibly affecting KIAA0141 through downstream signaling events. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
Calcium ionophore similar to ionomycin, potentially affecting KIAA0141 activity through modulation of calcium signaling. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
A cAMP analog that activates protein kinase A (PKA), potentially affecting signaling cascades that lead to KIAA0141 activation. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Inhibitor of protein phosphatases PP1 and PP2A, potentially altering phosphorylation states that could influence KIAA0141 activity. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Inhibits protein synthesis and also activates stress-activated protein kinases, which could indirectly affect KIAA0141 activity. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
A permeable cAMP analog that activates PKA, potentially influencing signaling pathways that could increase KIAA0141 activity. | ||||||
Sodium nitroprusside dihydrate | 13755-38-9 | sc-203395 sc-203395A sc-203395B | 1 g 5 g 100 g | $43.00 $85.00 $158.00 | 7 | |
Donor of nitric oxide, which may influence signaling pathways and thus potentially increase KIAA0141 functional activity. | ||||||